Kazimieras Melaika

Kazimieras Melaika, MD is a clinical trial coordinator at VUL Santaros klinikos for Phase 3 international studies conducted by pharmaceutical companies like Janssen and Bayer. They have a background in neurology as a resident doctor at Fleming and VUL Santaros klinikos, as well as experience in medical research and regulatory compliance. Kazimieras also has experience as a laboratory assistant at VU Life Sciences Center and as a lead organizer at United School of Neurosciences. In addition, they have volunteered in COVID-19 related roles, including at the National Center of Public Health and in the Intensive Care Unit at VUL Santaros klinikos. Their educational background includes a Doctor of Medicine degree from Vilnius University.